The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Replication Gaps Underlie BRCA Deficiency and Therapy Response
Open accessPublished version of a preprint
Abstract
Defects in DNA repair and the protection of stalled DNA replication forks are thought to underlie the chemosensitivity of tumors deficient in the hereditary breast cancer genes BRCA1 and BRCA2 (BRCA). Challenging this assumption are recent findings that indicate chemotherapies, such as cisplatin used to treat BRCA-deficient tumors, do not initially cause DNA double-strand breaks (DSB). Here, we show that ssDNA replication gaps underlie the hypersensitivity of BRCA-deficient cancer and that defects in homologous recombination (HR) or fork protection (FP) do not. In BRCA-deficient cells, ssDNA gaps developed because replication was not effectively restrained in response to stress. Gap suppression by either restoration of fork restraint or gap filling conferred therapy resistance in tissue culture and BRCA patient tumors. In contrast, restored FP and HR could be uncoupled from therapy resistance when gaps were present. Moreover, DSBs were not detected after therapy when apoptosis was inhibited, supporting a framework in which DSBs are not directly induced by genotoxic agents, but rather are induced from cell death nucleases and are not fundamental to the mechanism of action of genotoxic agents. Together, these data indicate that ssDNA replication gaps underlie the BRCA cancer phenotype, “BRCAness,” and we propose they are fundamental to the mechanism of action of genotoxic chemotherapies. Significance: This study suggests that ssDNA replication gaps are fundamental to the toxicity of genotoxic agents and underlie the BRCA-cancer phenotype “BRCAness,” yielding promising biomarkers, targets, and opportunities to resensitize refractory disease. See related commentary by Canman, p. 1214
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Schlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514
Chudnovsky, Y., Kim, D., Zheng, S., Whyte, W. A., Bansal, M., Bray, M.-A., Gopal, S., Theisen, M. A., Bilodeau, S., Thiru, P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.032 · Cited by 136
Research works printed but not linked: 52
- King, 1986, Genetic analysis of human breast cancer: literature review and description of family data in workshop, Genet Epidemiol Suppl, 1, 3
- Munnell, 1968, The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952–1961, Am J Obstet Gynecol, 100, 790, 10.1016/S0002-9378(15)33580-8 · doi:10.1016/s0002-9378(15)33580-8
- Li, 2008, Homologous recombination in DNA repair and DNA damage tolerance, Cell Res, 18, 99, 10.1038/cr.2008.1 · DOI · Paper page
- Feng, 2017, Homologous recombination and replication fork protection: BRCA2 and more!, Cold Spring Harb Symp Quant Biol, 82, 329, 10.1101/sqb.2017.82.035006 · DOI
- Lomonosov, 2003, Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein, Genes Dev, 17, 3017, 10.1101/gad.279003 · DOI · Paper page
- Schlacher, 2011, Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11, Cell, 145, 529, 10.1016/j.cell.2011.03.041 · DOI · Paper page
- Huang, 2013, The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks, Mol Cell, 52, 434, 10.1016/j.molcel.2013.09.021 · DOI · Paper page
- Mutreja, 2018, ATR-mediated global fork slowing and reversal assist fork traverse and prevent chromosomal breakage at DNA interstrand cross-links, Cell Rep, 24, 2629, 10.1016/j.celrep.2018.08.019 · DOI
- Cantor, 2017, Fork protection and therapy resistance in hereditary breast cancer, Cold Spring Harb Symp Quant Biol, 82, 339, 10.1101/sqb.2017.82.034413 · DOI
- Bunting, 2012, BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair, Mol Cell, 46, 125, 10.1016/j.molcel.2012.02.015 · DOI · Paper page
- Wang, 2015, A dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination, Mol Cell, 59, 478, 10.1016/j.molcel.2015.07.009 · DOI · Paper page
- Barazas, 2019, Radiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors, Cancer Res, 79, 452, 10.1158/0008-5472.CAN-18-2077 · DOI
- Bruno, 2017, A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress, Nat Med, 23, 461, 10.1038/nm.4291 · DOI · Paper page
- Heijink, 2019, Modeling of cisplatin-induced signaling dynamics in triple-negative breast cancer cells reveals mediators of sensitivity, Cell Rep, 28, 2345, 10.1016/j.celrep.2019.07.070 · DOI
- Koc, 2004, Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools, J Biol Chem, 279, 223, 10.1074/jbc.M303952200 · DOI · Paper page
- Ray Chaudhuri, 2016, Replication fork stability confers chemoresistance in BRCA-deficient cells, Nature, 535, 382, 10.1038/nature18325 · DOI · Paper page
- Sakai, 2009, Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma, Cancer Res, 69, 6381, 10.1158/0008-5472.CAN-09-1178 · DOI · Paper page
- Quinet, 2017, DNA fiber analysis: mind the gap!, Methods Enzymol, 591, 55, 10.1016/bs.mie.2017.03.019 · DOI · Paper page
- Guillemette, 2015, Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4, Genes Dev, 29, 489, 10.1101/gad.256214.114 · DOI
- O’Shaughnessy, 2013, CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now, Biochem Soc Trans, 41, 777, 10.1042/BST20130027 · DOI
- Rondinelli, 2017, EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation, Nat Cell Biol, 19, 1371, 10.1038/ncb3626 · DOI · Paper page
- Meghani, 2018, Multifaceted impact of microRNA 493-5p on genome-stabilizing pathways induces platinum and PARP inhibitor resistance in BRCA2-mutated carcinomas, Cell Rep, 23, 100, 10.1016/j.celrep.2018.03.038 · DOI
- Mengwasser, 2019, Genetic screens reveal FEN1 and APEX2 as BRCA2 synthetic lethal targets, Mol Cell, 73, 885, 10.1016/j.molcel.2018.12.008 · DOI · Paper page
- Taglialatela, 2017, Restoration of replication fork stability in BRCA1- and BRCA2-deficient cells by inactivation of SNF2-family fork remodelers, Mol Cell, 68, 414, 10.1016/j.molcel.2017.09.036 · DOI · Paper page
- Kolinjivadi, 2017, Smarcal1-mediated fork reversal triggers Mre11-dependent degradation of nascent DNA in the absence of Brca2 and stable Rad51 nucleofilaments, Mol Cell, 67, 867, 10.1016/j.molcel.2017.07.001 · DOI · Paper page
- Bhat, 2018, RADX modulates RAD51 activity to control replication fork protection, Cell Rep, 24, 538, 10.1016/j.celrep.2018.06.061 · DOI
- Zellweger, 2015, Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells, J Cell Biol, 208, 563, 10.1083/jcb.201406099 · DOI · Paper page
- Van Noorden, 2001, The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition, Acta Histochem, 103, 241, 10.1078/0065-1281-00601 · DOI
- Henry-Mowatt, 2003, XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes, Mol Cell, 11, 1109, 10.1016/S1097-2765(03)00132-1 · DOI · Paper page
- Sugimura, 2008, PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA, J Cell Biol, 183, 1203, 10.1083/jcb.200806068 · DOI · Paper page
- Su, 2008, Cell-cycle coordination between DNA replication and recombination revealed by a vertebrate N-end rule degron-Rad51, Nat Struct Mol Biol, 15, 1049, 10.1038/nsmb.1490 · DOI
- Hashimoto, 2010, Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis, Nat Struct Mol Biol, 17, 1305, 10.1038/nsmb.1927 · DOI · Paper page
- Luke-Glaser, 2010, FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling, EMBO J, 29, 795, 10.1038/emboj.2009.371 · DOI
- Vallerga, 2015, Rad51 recombinase prevents Mre11 nuclease-dependent degradation and excessive PrimPol-mediated elongation of nascent DNA after UV irradiation, Proc Natl Acad Sci U S A, 112, E6624, 10.1073/pnas.1508543112 · DOI
- Kolinjivadi, 2017, Moonlighting at replication forks - a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51, FEBS Lett, 591, 1083, 10.1002/1873-3468.12556 · DOI
- Wong, 2020, Processing of DNA polymerase-blocking lesions during genome replication is spatially and temporally segregated from replication forks, Mol Cell, 77, 3, 10.1016/j.molcel.2019.09.015 · DOI
- Elvers, 2011, UV stalled replication forks restart by re-priming in human fibroblasts, Nucleic Acids Res, 39, 7049, 10.1093/nar/gkr420 · DOI
- Mourón, 2013, Repriming of DNA synthesis at stalled replication forks by human PrimPol, Nat Struct Mol Biol, 20, 1383, 10.1038/nsmb.2719 · DOI · Paper page
- Bianchi, 2013, PrimPol bypasses UV photoproducts during eukaryotic chromosomal DNA replication, Mol Cell, 52, 566, 10.1016/j.molcel.2013.10.035 · DOI · Paper page
- Xu, 2019, BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy, Hum Mol Genet, 28, 842, 10.1093/hmg/ddy398 · DOI
- Mijic, 2017, Replication fork reversal triggers fork degradation in BRCA2-defective cells, Nat Commun, 8, 859, 10.1038/s41467-017-01164-5 · DOI · Paper page
- Zimmermann, 2018, CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions, Nature, 559, 285, 10.1038/s41586-018-0291-z · DOI · Paper page
- Faivre, 2003, DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells, Biochem Pharmacol, 66, 225, 10.1016/S0006-2952(03)00260-0 · DOI · Paper page
- Sane, 1998, Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities, Cancer Res, 58, 3066
- Nowosielska, 2005, Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants, DNA Repair, 4, 773, 10.1016/j.dnarep.2005.03.006 · DOI
- Kawane, 2014, DNA degradation and its defects, Cold Spring Harb Perspect Biol, 6, a016394, 10.1101/cshperspect.a016394 · DOI
- Sakahira, 1998, Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis, Nature, 391, 96, 10.1038/34214 · DOI · Paper page
- Huang, 1996, Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest, Proc Natl Acad Sci U S A, 93, 4827, 10.1073/pnas.93.10.4827 · DOI · Paper page
- Tidd, 2000, Oligodeoxynucleotide 5mers containing a 5′-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cells, Nucleic Acids Res, 28, 2242, 10.1093/nar/28.11.2242 · DOI
- Nayak, 2020, Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability, Sci Adv, 6, eaaz7808, 10.1126/sciadv.aaz7808 · DOI
- Tonzi, 2019, Role of Y-family translesion DNA polymerases in replication stress: implications for new cancer therapeutic targets, DNA Repair, 78, 20, 10.1016/j.dnarep.2019.03.016 · DOI
- Cong, 2019, PARPi synthetic lethality derives from replication-associated single-stranded DNA gaps, bioRxiv, 781989
Cited by
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Cong, K., Peng, M., Kousholt, A. N., Lee, W. T. C., Lee, S., Nayak, S., Krais, J., VanderVere-Carozza, P. S., Pawelczak, K. S., Calvo, J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.011 · Cited by 345
Self-citationBélanger, F., Roussel, C., Sawchyn, C., St-Hilaire, E., Gezzar-Dandashi, S., Kimenyi Ishimwe, A. B., Mallette, F. A., Wurtele, H., & Drobetsky, E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104900 · Cited by 9
Metadata
- Authors
- Panzarino, N. J., Krais, J. J., Cong, K., Peng, M., Mosqueda, M., Nayak, S. U., Bond, S. M., Calvo, J. A., Doshi, M. B., Bere, M., Ou, J., Deng, B., Zhu, L. J., Johnson, N., & Cantor, S. B.
- Venue
- Cancer Research
- Published
- 2021-03-01
- Volume
- 81
- Issue
- 5
- Pages
- 1388-1397
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W3099886820
- Cited by
- 212
- References
- 7
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Foundation for the National Institutes of Health (R01 CA225018-02, R01 CA247232, R01 CA254037, R01 CA214799)
- U.S. Department of Defense (OC130212)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Replication Gaps Underlie BRCA Deficiency and Therapy Response. https://app.cochat.ai/papers/10.1158/0008-5472.can-20-1602
- The paper
- Panzarino, N. J., Krais, J. J., Cong, K., Peng, M., Mosqueda, M., Nayak, S. U., Bond, S. M., Calvo, J. A., Doshi, M. B., Bere, M., Ou, J., Deng, B., Zhu, L. J., Johnson, N., & Cantor, S. B. (2021). Replication Gaps Underlie BRCA Deficiency and Therapy Response. Cancer Research. https://doi.org/10.1158/0008-5472.can-20-1602
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.